COMMENT ON MITOXANTRONE

被引：14

作者：

DUKART, G ^{[1
]}

IATROPOULOS, MJ ^{[1
]}

YACOBI, A ^{[1
]}

机构：

[1] AMER CYANAMID CO,LEDERLE LABS,DIV MED RES,PEARL RIVER,NY 10965

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1985年 / 19卷 / 03期

关键词：

D O I：

10.1177/106002808501900317

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：216 / 218

页数：3

共 14 条

[1]

ADAMSON RH, 1974, CANCER CHEMOTH REP 1, V58, P293

[2] SERIAL ASSESSMENT OF DOXORUBICIN CARDIOTOXICITY WITH QUANTITATIVE RADIONUCLIDE ANGIOCARDIOGRAPHY [J].

ALEXANDER, J ;

DAINIAK, N ;

BERGER, HJ ;

GOLDMAN, L ;

JOHNSTONE, D ;

REDUTO, L ;

DUFFY, T ;

SCHWARTZ, P ;

GOTTSCHALK, A ;

ZARET, BL .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (06) :278-283

[3]

BENJAMIN RS, 1984, MAY AM SOC CLIN ONC

[4] MITOXANTRONE - A REPLACEMENT FOR DOXORUBICIN [J].

CONNER, CS .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06) :479-480

[5] COMPARATIVE CARDIAC OXYGEN RADICAL METABOLISM BY ANTHRACYCLINE ANTIBIOTICS, MITOXANTRONE, BISANTRENE, 4'-(9-ACRIDINYLAMINO)-METHANESULFON-META-ANISIDIDE, AND NEOCARZINOSTATIN [J].

DOROSHOW, JH ;

DAVIES, KJA .

BIOCHEMICAL PHARMACOLOGY, 1983, 32 (19) :2935-2939

[6]

DOROSHOW JH, 1983, CANCER RES, V43, P4543

[7]

DUKART G, 1984, PHARMANUAL COMPREHEN

[8]

FENOGLIO JJ, 1983, CARDIOVASC PATHOL, V2, P1085

[9]

HENDERSON IC, 1984, MAY AM SOC CLIN ONC

[10]

IATROPOULOS MJ, 1984, CANCER TREAT S, V3, P380

← 1 2 →